levonorgestrel has been researched along with norethindrone enanthate in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (31.25) | 18.7374 |
| 1990's | 6 (37.50) | 18.2507 |
| 2000's | 1 (6.25) | 29.6817 |
| 2010's | 4 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cullins, VE | 1 |
| Shaaban, MM | 1 |
| Garza-Flores, J; Hall, PE; Perez-Palacios, G | 1 |
| Keller, PJ | 1 |
| Odlind, V | 1 |
| Fraser, IS | 1 |
| Cruickshank, J; McMaster, M; Weir, RJ; Wilson, ES | 1 |
| Affandi, B; Hadisaputra, W; Rogers, PA; Siregar, B; Wonodirekso, S | 1 |
| González, EA; Molina, RC; Molina, TG; Montero, AV; Oyarzún, PG; Sandoval, JZ | 1 |
| Weisberg, E | 1 |
| Gallo, MF; Grimes, DA; Halpern, V; Lopez, LM; Nanda, K; Schulz, KF | 1 |
| Callahan, R; Halpern, V; Nanda, K; Yacobson, I | 1 |
| Achilles, SL; Austin, MN; Chirenje, ZM; Hillier, SL; Meyn, LA; Mhlanga, F | 1 |
6 review(s) available for levonorgestrel and norethindrone enanthate
| Article | Year |
|---|---|
Injectable and implantable contraceptives.
Topics: Capsules; Contraceptive Agents, Female; Drug Implants; Humans; Injections; Levonorgestrel; Medroxyprogesterone; Medroxyprogesterone Acetate; Microspheres; Norethindrone | 1992 |
Long-acting hormonal contraceptives for women.
Topics: Aniline Compounds; Contraceptive Agents, Female; Delayed-Action Preparations; Drug Implants; Female; Humans; Levonorgestrel; Norethindrone; Norethindrone Acetate; Ovulation | 1991 |
[Hormonal contraception using depot preparations].
Topics: Abnormalities, Drug-Induced; Blood Coagulation; Carbohydrate Metabolism; Cardiovascular Diseases; Contraceptive Agents, Female; Delayed-Action Preparations; Female; Humans; Infant, Newborn; Levonorgestrel; Liver; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasms; Norethindrone; Norgestrel; Pregnancy; Risk | 1986 |
New delivery systems for hormonal contraception.
Topics: Contraceptive Agents, Female; Drug Implants; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Medroxyprogesterone; Medroxyprogesterone Acetate; Norethindrone; Norgestrel; Pregnancy; Progesterone; Progestins; Research; Time Factors; Vagina | 1986 |
Steroid hormones for contraception in men.
Topics: Azoospermia; Contraception; Contraceptive Agents, Male; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Synthetic; Desogestrel; Drug Implants; Humans; Levonorgestrel; Male; Norethindrone; Oligospermia; Randomized Controlled Trials as Topic; Testosterone | 2012 |
Ectopic pregnancy with use of progestin-only injectables and contraceptive implants: a systematic review.
Topics: Contraception; Contraceptive Agents, Female; Desogestrel; Drug Implants; Female; Humans; Incidence; Injections; Levonorgestrel; Medroxyprogesterone Acetate; Norethindrone; Pregnancy; Pregnancy, Ectopic; Progestins | 2015 |
4 trial(s) available for levonorgestrel and norethindrone enanthate
| Article | Year |
|---|---|
Contraception with progestogens and progesterone during lactation.
Topics: Contraceptive Devices, Female; Humans; Infant Nutritional Physiological Phenomena; Infant, Newborn; Lactation; Levonorgestrel; Medroxyprogesterone; Medroxyprogesterone Acetate; Milk, Human; Norethindrone; Progesterone; Psychophysiology | 1991 |
A prospective controlled study of the effect on blood pressure of contraceptive preparations containing different types and dosages of progestogen.
Topics: Adolescent; Adult; Blood Pressure; Clinical Trials as Topic; Contraceptives, Oral; Contraceptives, Oral, Combined; Ethinyl Estradiol; Ethynodiol Diacetate; Female; Humans; Levonorgestrel; Middle Aged; Norethindrone; Norethindrone Acetate; Norgestrel; Prospective Studies; Stereoisomerism | 1984 |
Progestogen-only contraceptives during lactation: I. Infant growth. World Health Organization Task force for Epidemiological Research on Reproductive Health; Special Programme of Research, Development and Research Training in Human Reproduction.
Topics: Adolescent; Adult; Anthropometry; Body Weight; Child Development; Chile; Contraceptive Agents, Female; Drug Implants; Egypt; Female; Humans; Hungary; Infant; Kenya; Lactation; Levonorgestrel; Medroxyprogesterone Acetate; Norethindrone; Pregnancy; Progestins; Prospective Studies; Thailand | 1994 |
Progestogen-only contraceptives during lactation: II. Infant development. World Health Organization, Task Force for Epidemiological Research on Reproductive Health; Special Programme of Research, Development, and Research Training in Human Reproduction.
Topics: Adolescent; Adult; Child Development; Chile; Contraceptive Agents, Female; Drug Implants; Egypt; Female; Humans; Hungary; Infant; Kenya; Lactation; Levonorgestrel; Medroxyprogesterone Acetate; Norethindrone; Pregnancy; Progestins; Prospective Studies; Thailand | 1994 |
6 other study(ies) available for levonorgestrel and norethindrone enanthate
| Article | Year |
|---|---|
Menstrual changes associated with progestogen-only contraception.
Topics: Administration, Oral; Amenorrhea; Contraceptive Agents, Female; Counseling; Estrogens; Female; Humans; Levonorgestrel; Medroxyprogesterone; Medroxyprogesterone Acetate; Menstruation Disturbances; Norethindrone; Norgestrel; Time Factors | 1986 |
Long-acting progestins--promise and prospects.
Topics: Animals; Bibliographies as Topic; Breast Neoplasms; Contraceptives, Oral, Combined; Delayed-Action Preparations; Dogs; Female; Haplorhini; Humans; Injections, Intramuscular; Intrauterine Devices, Medicated; Levonorgestrel; Medroxyprogesterone; Medroxyprogesterone Acetate; Norethindrone; Norgestrel; Progesterone Congeners; Rats; Reproduction; Uterine Neoplasms | 1983 |
Cytokeratin 8, 18 and 19 in endometrial epithelium of Norplant and norethisterone enanthate injectable progestogen contraceptive users.
Topics: Adult; Animals; Antibodies, Monoclonal; Biopsy; Contraceptive Agents, Female; Endometrium; Female; Humans; Immunohistochemistry; Keratins; Levonorgestrel; Mice; Norethindrone | 1996 |
Comparative performance of a combined injectable contraceptive (50 mg norethisterone enanthate plus 5mg estradiol valerate) and a combined oral contraceptive (0.15 mg levonorgestrel plus 0.03 mg ethinyl estradiol) in adolescents.
Topics: Adolescent; Ambulatory Care Facilities; Contraceptives, Oral, Combined; Drug Administration Schedule; Drug Combinations; Estradiol; Ethinyl Estradiol; Female; Humans; Injections, Intramuscular; Levonorgestrel; Medication Adherence; Norethindrone; Patient Satisfaction; Prospective Studies; Young Adult | 2009 |
Contraceptive options for women in selected circumstances.
Topics: Adolescent; Adult; Anemia; Breast Diseases; Cardiovascular Diseases; Condoms; Contraception; Contraceptive Agents, Female; Contraindications; Desogestrel; Diabetes Mellitus; Drug Combinations; Drug Implants; Epilepsy; Ethinyl Estradiol; Female; Heart Valve Diseases; Humans; Hypertension; Inflammatory Bowel Diseases; Injections; Intrauterine Devices; Levonorgestrel; Liver Diseases; Lupus Erythematosus, Systemic; Medroxyprogesterone Acetate; Migraine Disorders; Norethindrone; Norgestrel; Obesity; Patient Preference; Pregnancy; Progestins; Stroke; Young Adult | 2010 |
Impact of contraceptive initiation on vaginal microbiota.
Topics: Adult; Contraceptive Agents, Female; Desogestrel; DNA, Bacterial; Drug Implants; Ethinyl Estradiol; Female; Gardnerella vaginalis; Humans; Intrauterine Devices, Copper; Lactobacillus crispatus; Lactobacillus gasseri; Levonorgestrel; Medroxyprogesterone Acetate; Megasphaera; Microbiota; Norethindrone; Polymerase Chain Reaction; Protective Factors; Risk Factors; Vagina; Vaginosis, Bacterial; Young Adult | 2018 |